TABLE 3

Effect of the Intervention on Child 7-d Morbidity Symptoms in a Randomized Controlled Trial of Eggs in Ecuador

BaselineEnd PointPRPR
Control (n = 82)Egg (n = 78)Control (n = 73)Egg (n = 75)UnadjustedAdjusteda
β (95% CI)Pβ (95% CI)P
Fever29 (35%)27 (35%)18 (24%)24 (32%)1.33 (0.79–2.25).281.44 (0.86–2.42).17
Respiratory conditions
 Difficulty breathing21 (26%)25 (32%)7 (10%)6 (8%).86 (0.30–2.44).771.05 (0.32–3.39).94
 Cough34 (42%)40 (51%)24 (32%)29 (39%)1.21 (0.78–1.87).401.25 (0.94–1.39).33
 Congestion35 (43%)37 (47%)18 (24%)31 (42%)1.72 (1.06–2.80).401.61 (0.98–2.62).06
Acute diarrhea12 (15%)20 (26%)11 (15%)23 (31%)2.09 (1.10–3.98).031.97 (0.99–3.89).05
Skin conditions
 Rash31 (38%)21 (27%)17 (23%)10 (14%).59 (0.29–1.20).15.61 (0.29–1.26).18
 Bruises, scraps, cuts14 (17%)13 (17%)11 (15%)6 (8%).55 (0.21–1.40).21.47 (0.19–1.16).10
Toothache and/or teething9 (11%)9 (12%)8 (11%)5 (7%).63 (0.21–1.83).39.64 (0.22–1.84).41
  • Table shows results for baseline and end-point prevalence (no. [%] of morbidity) symptoms by weekly recall and GLM modeling with robust Poisson.

  • a Adjusted for child age, sex of the child, and baseline morbidity symptoms for the same dependent variable.